glp-1 receptor agonists weight loss effectiveness for reduction in people living with obesity but without diabetes: a living benefit–harm modelling study The role of glucagon-like peptide-1

This is particularly relevant in the context of reducing the number of meals per day

The distinction between IM and subcutaneous is unlikely to be clinically meaningful given the absence of human pharmacokinetic benchmarks for either route

In anabolic events, such as the manufacture of cholesterol and nucleic acids, the elongation of fatty acids, and the regeneration of glutathione, a vital antioxidant in the body, NADP+ and NADPH are frequently involved

Bioinformatic analysis has identified a diverse set of residues that are critical for CHAC1 activity and collectively form its active site (Suyal et al., 2023)

Iranian Journal of Allergy, Asthma and Immunology 21 (3): 332343